Related Experiment Video
Updated: Jun 21, 2026

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
Published on: July 6, 2019
A joint model for multiple dynamic processes and clinical endpoints: Application to Alzheimer's disease
Cécile Proust-Lima1, Viviane Philipps1, Jean-François Dartigues1
1INSERM, Bordeaux Population Health Research Center, UMR 1219, Univ. Bordeaux, F-33000, Bordeaux, France.
This study introduces a novel joint statistical model to analyze multiple Alzheimer's disease (AD) impairments simultaneously. This approach better reflects the interconnected progression of AD, improving our understanding of dementia development.
Area of Science:
- Neuroscience
- Biostatistics
- Gerontology
Background:
- Alzheimer's disease (AD) involves progressive brain impairments affecting cognition and function.
- Previous studies analyzed AD components independently due to a lack of joint statistical models.
- Interrelatedness of AD progression necessitates a unified analytical approach.
Purpose of the Study:
- To propose a novel joint model for analyzing multiple correlated components in Alzheimer's disease.
- To simultaneously describe the dynamics of latent processes and their relationship to diagnosis.
- To accommodate competing clinical endpoints within the model.
Main Methods:
- Developed a joint model for multivariate longitudinal data and time-to-event analysis.
- Modeled diagnosis as exceeding a covariate-specific threshold of a combined pathological process.
- Utilized a maximum likelihood estimation procedure, implemented in an R package.
- Handled competing risks for clinical endpoints.
Main Results:
- The proposed model successfully integrates multiple correlated disease components.
- The estimation procedure is computationally feasible and robust, validated by simulations.
- The method was applied to a French cohort, analyzing clinical manifestations and risks of dementia and death.
Conclusions:
- Joint modeling provides a more comprehensive understanding of Alzheimer's disease progression.
- The new statistical framework can capture the complexity of dementia diagnosis.
- This approach offers a valuable tool for analyzing longitudinal data in neurodegenerative disease research.
More Related Videos
09:47DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
Published on: December 15, 2023
05:39A Fine Motor Task to Study Joint Kinematics in a Preclinical Model of Neurodegenerative Disease
Published on: June 13, 2025
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment
Pharmacodynamic Models: Overview
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Alzheimer Disease l: Introduction
Alzheimer Disease ll: Pathophysiology